Joseph R. G. Rinka

Adequacy of Hemostatic Resuscitation Improves Therapeutic Efficacy of Recombinant Activated Factor VII and Reduces Reexploration Rate for Bleeding in Postoperative Cardiac Surgery Patients with Refractory Hemorrhage

P. Pagel, Joel T. Feih, Janelle J Juul, 2019, Annals of cardiac anaesthesia.

Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.

Joel T. Feih, M. Zundel, Joseph R. G. Rinka, 2019, Journal of cardiothoracic and vascular anesthesia.

Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases.

Julie K. Freed, P. Pagel, Joel T. Feih, 2017, Journal of cardiothoracic and vascular anesthesia.

Argatroban Versus Bivalirudin in the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia

Joel T. Feih, Joseph R G Rinka, Justin N. Tawil, 2019, Journal of pharmacy practice.

131

T. Pang, Lisa Baumann Kruetziger, Joel T. Feih, 2019, Critical Care Medicine.

Heparin Monitoring with an Anti-Xa Protocol Compared to Activated Clotting Time in Patients on Temporary Mechanical Circulatory Support

L. Baumann Kreuziger, Joel T. Feih, N. Gaglianello, 2021, The Annals of pharmacotherapy.

149

Joel T. Feih, Danielle M. Mabrey, J. Cowell, 2019, Critical Care Medicine.